Real-time enrollment status for this triple negative breast cancer clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 1:39 PM UTC
| NCT Number | NCT03090165 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Triple Negative Breast Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 37 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Kari Wisinski |
| Last Updated on CT.gov | January 2, 2026 (Jan 2, 2026) |
As of March 2, 2026: Clinical trial NCT03090165 is currently active_not_recruiting participants. This clinical trial study for triple negative breast cancer is not currently accepting new participants at 6 locations across the United States. The study is sponsored by Kari Wisinski. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT03090165 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03090165 was last updated Jan 2, 2026 (January 2, 2026). HelloStudys verifies this status automatically.